La compañía se suma nuevamente a la iniciativa impulsada por la Fundación "la Caixa" en colaboración con Gavi, the Vaccine Alliance. Esta acción solidaria respalda el ODS3 de las Naciones Unidas,...
Read more
La investigación incorpora nuevos conceptos en esta enfermedad, como la biopsia líquida intraoperatoria, que puede aportar una valiosa información para evitar que el tumor crezca de nuevo o se exti...
Read more
A scientific team at IRB Barcelona has, for the first time, described which hybrid triplexes (DNA-RNA) are most stable within the cell and how they are distributed throughout the human genome.
Read more
Oryzon Genomics announced today that the first patient has been dosed in a Phase I/II trial of iadademstat, Oryzon’s potent and selective LSD1 inhibitor, in combination with immune checkpoint inhibi...
Read more
The patent, titled “Methods of treating Attention Deficit Hyperactivity Disorder using KDM1A inhibitors such as the compound vafidemstat”, covers the use Oryzon’s LSD1 inhibitor, vafidemstat, cu...
Read more
Researchers from the Endocrine Tumours group at the Germans Trias i Pujol Research Institute (IGTP), in collaboration with five university hospitals, have conducted the first comprehensive study of DN...
Read more
Un estudio revela cómo la diabetes gestacional materna influye en la metilación del ADN infantil, una modificación epigenética, lo que podría afectar el desarrollo metabólico y el riesgo de enfe...
Read more
La Asociación Española Contra el Cáncer ha presentado en Elche sus ayudas a la investigación en la provincia de Alicante, que suponen un total de 658.535€.
Read more
Oryzon to validate epigenetic agents by applying a personalized medicine approach for rare and orphan diseases
Read more
These findings suggest that the IRS1 gene could serve as an early epigenetic marker for identifying children at higher risk of developing metabolic disorders. This could pave the way for much earlier ...
Read more
The review highlights the great leaps made in recent years, such as the emergence of immunotherapy or targeted therapies, but it also indicates the pending challenges, such as improving early diagnosi...
Read more
Oryzon Genomics, S.A., a clinical-stage biopharmaceutical company and a European leader in epigenetics, announced today that its management will give an update on corporate progress at several intern...
Read more
La mejor actitud que podemos adoptar es la de trat...
The research team observed changes in head circumf...
AtCDF3 gene induced greater production of sugars a...
En nuestro post hablamos sobre este interesante tipo de célula del...
Telum Therapeutics, a biotechnology company leveraging proprietary met...
